Systolic blood pressure (mmHg), change from baseline · adults with established cardiovascular disease
1 finding from 1 review
Diastolic blood pressure (mmHg), change from baseline · adults with established cardiovascular disease
1 finding from 1 review
Adverse events · adults with established cardiovascular disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
LDL cholesterol (mmol/L), change from baseline · adults without cardiovascular disease
1 finding from 1 review
HDL cholesterol (mmol/L), change from baseline · adults without cardiovascular disease
1 finding from 1 review
Triglycerides (mmol/L), change from baseline · adults without cardiovascular disease
1 finding from 1 review
Systolic blood pressure (mmHg), change from baseline · adults without cardiovascular disease
1 finding from 1 review
Diastolic blood pressure (mmHg), change from baseline · adults without cardiovascular disease
1 finding from 1 review
Adverse events · adults without cardiovascular disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Prodromal symptoms: transition to psychosis Endpoint data (events) · people in the prodromal stage of psychosis
It is very uncertain whether group B antipsychotic drugs: olanzapine + supportive intervention changes prodromal symptoms: transition to psychosis Endpoint data, (events)… compared with placebo + supportive intervention (very low certainty).
1 finding from 1 review
Global effect: 1a. Medium‐term ‐ Average end point score on various outcomes ‐ CGI‐severity (low = favourable) ( · people in the prodromal stage of psychosis
1 finding from 1 review
Mental state: psychosis risk symptoms SOPS total (higher score = worse, scale from: 0‐114) · people in the prodromal stage of psychosis
1 finding from 1 review
Behaviour: clinically important change in behaviour · people in the prodromal stage of psychosis
1 finding from 1 review
Weight gain · people in the prodromal stage of psychosis
1 finding from 1 review
Quality of life: clinically important change in quality of life · people in the prodromal stage of psychosis
1 finding from 1 review
Satisfaction and acceptability of treatment (medium term) ‐ leaving the study early · people in the prodromal stage of psychosis
It is very uncertain whether group B antipsychotic drugs: olanzapine + supportive intervention changes satisfaction with treatment: leaving the study early Endpoint data… compared with placebo + supportive intervention (very low certainty).
1 finding from 1 review
Abstinence · Pregnant women who smoke
Outcomes for all interventions for smoking cessation in pregnancy leads to higher abstinence at 0 to 5 months postpartum compared with control: subgrouped by main intervention strategy (comparison 20) (high certainty).
2 findings from 1 review
Birthweight < 2500 (g) · Pregnant women who smoke
Outcomes for all interventions for smoking cessation in pregnancy leads to lower low birthweight (under 2500 g) compared with control: subgrouped by main intervention strategy (comparison 20) (high certainty).
1 finding from 1 review
Gestational age (preterm birth < 37 weeks) · Pregnant women who smoke
Outcomes for all interventions for smoking cessation in pregnancy showed no clear difference in preterm birth (under 37 weeks) compared with control: subgrouped by main intervention strategy (comparison 20) (high certainty).
1 finding from 1 review
Mean birthweight · Pregnant women who smoke
Outcomes for all interventions for smoking cessation in pregnancy showed no clear difference in mean birthweight (g) compared with control: subgrouped by main intervention strategy (comparison 20) (high certainty).
1 finding from 1 review